Identification of Risk Factors for Diabetes Type 2 and Components of Pharmacists' Interventions in Community Pharmacy Setting: A Serbian Pilot Study

被引:1
|
作者
Tasic, Ljiljana [1 ]
Pesic, Vukica Kocic [2 ]
机构
[1] Univ Belgrade, Fac Pharm, Dept Social Pharm & Pharmaceut Legislat, V Stepe Str 450, Belgrade 11221, Serbia
[2] ADOC Co, Dept Res & Qual, Belgrade, Serbia
关键词
Prevention; Type 2 Diabetes Mellitus; Pharmacists' Intervention; Complex intervention; Community Pharmacy; SYSTEMATIC REVIEWS; PROGRAM; IMPACT; CARE; MANAGEMENT; SERVICES; GLUCOSE;
D O I
10.5530/ijper.50.1.12
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Prevention of Type 2 diabetes (T2D) is clinical service useful to implement on community pharmacy settings (CP). The objectives of study were: to determine the risk factors for T2D in adults visiting a community pharmacy; to determine and describe component of pharmacists' interventions (PI) focusing on feasibility of complex intervention (CI). A cross-sectional study design and conducted (January 2010 to June 2011) on 20 CP in Serbia. Adult population was enrolled (304 patients). The pharmacist trained for implementation of complex PI (screening and counseling session). The national Questionnaire for T2D risk estimation was used for screening and Intervention check list was design and used for process of counseling. The DEPICT (Descriptive Elements of Pharmacist Intervention Characterization Tool) was used to describe the component of CI. High and very high risk score was estimated in age group 45-54 (10.80%) forward in age group 55-64 (9.60%); into the cohort below 45 year the 59 adults has low T2D risk score. The average value of PI/per patients was 4.02. From the eight domain/component (operational descriptor in DEPICT) the main component are 'education and counseling' with four type (items) of intervention performed in counseling session. As a conclusion, the pharmacists in CP detected and scoring risk of T2D in Serbian adults' population. The number and type of PI in counseling session adequate to participants clinical profile. Feasibility of the CI within the CP in Serbia was proved. For the outcomes measurements and impact of PI, a proper endpoint and follow-up study design should be conduct.
引用
收藏
页码:90 / 102
页数:13
相关论文
共 50 条
  • [31] Detection of undiagnosed cases of diabetes type 2 in patients with risk factors at community pharmacies of Portugal
    Pilger, D.
    Santos, H.
    Fino, M. H.
    Caetano, M. F.
    Faus, M. J.
    Iglesias, P.
    ARS PHARMACEUTICA, 2007, 48 (04) : 387 - 396
  • [32] The correlations between angiopoietin like 8 and cardiometabolic risk factors in Saudi women with type 2 diabetes mellitus: A pilot study
    Mohammedsaeed, Walaa
    Binjawhar, Dalal
    DIABETES & VASCULAR DISEASE RESEARCH, 2024, 21 (03)
  • [33] The Risk Factors for Development of Type 2 Diabetes: Panasonic Cohort Study 4
    Saijo, Yuto
    Okada, Hiroshi
    Hamaguchi, Masahide
    Habu, Momoko
    Kurogi, Kazushiro
    Murata, Hiroaki
    Ito, Masato
    Fukui, Michiaki
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (01)
  • [34] Application of Novel Pharmacists' Risk in Pharmacotherapy (PHARIPH) Scale for Identification of Factors Affecting the Safety of Hospital Pharmacotherapy-An Observational Pilot Study
    Fedorowicz, Olga
    Rypicz, Lukasz
    Wiela-Hojenska, Anna
    Jazwinska-Tarnawska, Ewa
    Witczak, Izabela
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (03)
  • [35] Novel Risk Factors and the Prediction of Type 2 Diabetes in the Atherosclerosis Risk in Communities (ARIC) Study
    Raynor, L. A.
    Pankow, James S.
    Duncan, Bruce B.
    Schmidt, Maria I.
    Hoogeveen, Ron C.
    Pereira, Mark A.
    Young, J. Hunter
    Ballantyne, Christie M.
    DIABETES CARE, 2013, 36 (01) : 70 - 76
  • [36] INCREASED PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN NEWLY DIAGNOSED TYPE 2 DIABETES PATIENTS - A RETROSPECTIVE STUDY
    Roman, G.
    Teodorescu, G.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2021, 17 (03)
  • [37] Identification of Risk Factors for Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus
    Takamura, Kazuhisa
    Fujimoto, Shinichiro
    Mita, Tomoya
    Kawaguchi, Yuko Okano
    Kurita, Mika
    Kadowaki, Satoshi
    Kamo, Yuki
    Aoshima, Chihiro
    Nozaki, Yui Okada
    Takahashi, Daigo
    Kudo, Ayako
    Hiki, Makoto
    Tomizawa, Nobuo
    Ikeda, Fuki
    Satoh, Hiroaki
    Watada, Hirotaka
    Minamino, Tohru
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [38] Risk of gestational diabetes recurrence and the development of type 2 diabetes among women with a history of gestational diabetes and risk factors: a study among 18 clinical centers in China
    Wei, Yumei
    Juan, Juan
    Su, Rina
    Song, Geng
    Chen, Xu
    Shan, Ruiqin
    Li, Ying
    Cui, Shihong
    Fan, Shangrong
    Feng, Ling
    You, Zishan
    Meng, Haixia
    Cai, Yan
    Zhang, Cuilin
    Yang, Huixia
    CHINESE MEDICAL JOURNAL, 2022, 135 (06) : 665 - 671
  • [39] Risk Factors of Pancreatic Cancer in Patients With Type 2 Diabetes Mellitus: The Hong Kong Diabetes Study
    Chan, Raymond Ngai Chiu
    Lee, Teddy Tai Loy
    Chou, Oscar Hou In
    So, Jenny
    Chung, Cheuk To
    Dee, Edward Christopher
    Ng, Kenrick
    Tang, Pias
    Roever, Leonardo
    Liu, Tong
    Wong, Wing Tak
    Tse, Gary
    Lee, Sharen
    JOURNAL OF THE ENDOCRINE SOCIETY, 2022, 6 (11)
  • [40] Comparison of health education and drug therapy monitoring interventions in patients with cardiovascular risk factors attending a community pharmacy (FISFTES-PM Study)
    Bofi Martinez, Patricia
    Garcia Jimenez, Emilio
    Martinez Martinez, Fernando
    ATENCION PRIMARIA, 2015, 47 (03): : 141 - 148